NewsNew analysis method can lead to better cancer drugs

2nd November 2020by admin0
https://nfusion-tech.com/wp-content/uploads/2020/11/new-analysis-method-can-lead-to-better-cancer-drugs_5fa127d51f247.jpeg

While proteins on the surfaces of cells are the
targets for most drugs, refined methods are needed to analyze how
these membrane proteins are organized. Researchers at Karolinska
Institutet have developed a new DNA-based analytical method that
could contribute to the development of future drugs for breast and
other cancers. The study is published in Nature
Nanotechnology.

Leave a Reply

Your email address will not be published. Required fields are marked *

https://nfusion-tech.com/wp-content/uploads/2019/10/Logo_newfusion-footer.png
https://nfusion-tech.com/wp-content/uploads/2019/10/Logo_newfusion-footer.png
Subscribe

If you wish to receive our latest news in your email box, just subscribe to our newsletter. We won’t spam you, we promise!

    New Fusion

    The New Fusion technology is based on a phenomenon called triplet-triplet annihilation (TTA) which is a process in which two triplet excitons annihilate and produce a higher energy singlet exciton.

    Subscribe

    If you wish to receive our latest news in your email box, just subscribe to our newsletter. We won’t spam you, we promise!

      New Fusion

      The New Fusion technology is based on a phenomenon called triplet-triplet annihilation (TTA) which is a process in which two triplet excitons annihilate and produce a higher energy singlet exciton.

      Copyright @2020 New Fusion All Rights Reserved

      Designed by FallingBrick


      Warning: Creating default object from empty value in /homepages/9/d775151175/htdocs/nfusion-tech.com/wp-content/plugins/applauz/framework_bt_plugin/.framework_bt_plugin.php on line 1640